Market Overview:
The global contract pharmaceutical fermentation services market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biologics and biosimilars, rising R&D expenditure by pharmaceutical and biotechnology companies, and growing animal health industry. The contract pharmaceutical fermentation services market is segmented on the basis of type into development services and commercial services. Development services are further sub-segmented into process development, scale-up & technology transfer, formulation development, analytical testing & characterization, and others. Commercial services are sub-segmented into manufacturing & packaging service, regulatory affairs service, distribution service, and others.
Product Definition:
Contract Pharmaceutical Fermentation Services is a service whereby a contract research organization (CRO) provides fermentation services to the biopharmaceutical industry. This can include process development, scale-up, manufacturing and quality control. The importance of Contract Pharmaceutical Fermentation Services lies in the fact that it allows biopharmaceutical companies to outsource this complex and costly process, which can often be done more cost-effectively than if done in-house.
Development Services:
Development services are the activities required to initiate, optimize and finalize the drug development process. It includes tasks such as cell line establishment, fermentation setup & running, bioprocessing (initiation/monitoring), analytical testing and quality control. Development services include all the in-house expertise that a pharmaceutical company can utilize to speed up its drug development process.
Commercial Services:
Commercial services are the processes that a manufacturer undertakes to produce biologicals or biologics, which are used as medicines by doctors. These services include cell line development and production, fermentation of proteins and other such molecules in large quantities.
The global contract pharmaceutical fermentation services market is expected to grow at a lucrative rate during the forecast period owing to increasing demand for biopharmaceutical products globally.
Application Insights:
The application segment is segregated into pharmaceutical companies, biotechnology companies, animal health companies and others. The contract pharmaceutical fermentation services market is dominated by the pharmaceutical industry at a global level as these organizations are engaged in the development of new drugs and vaccines. This factor has led to an increase in demand for efficient production technologies that can be used by small-scale fermenters to produce high quality biopharmaceuticals on a commercial scale.
In terms of revenue, the animal health industry accounted for 20% share in 2017 owing to an increase in R&D activities pertaining to medicines for animals coupled with growing awareness about diseases that affect animals and human health.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017 owing to the presence of a large number of global players and increased R&D expenditure by companies. The region is expected to maintain its dominance throughout the forecast period on account of increasing outsourcing activities in this region. Asia Pacific is anticipated to be one of the fastest-growing regions during contract pharmaceutical manufacturing services over the forecast period, owing to factors such as rising healthcare spending, improving economic conditions and an increase in demand for low-cost medicines.
The market growth can also be attributed to growing biotechnology & pharmaceutical industries supported by favorable government policies & regulations aimed at promoting innovation.
Growth Factors:
- Increasing demand for biologics and biosimilars
- Rising prevalence of chronic diseases
- Growing number of clinical trials and research studies
- Technological advancements in contract pharmaceutical fermentation services
- Expansion of the biopharmaceutical industry
Scope Of The Report
Report Attributes
Report Details
Report Title
Contract Pharmaceutical Fermentation Services Market Research Report
By Type
Development Services, Commercial Services
By Application
Pharmaceutical Companies, Biotechnology Companies, Animal Health Companies, Others
By Companies
AbbVie, Boehringer Ingelheim, Lonza, AMRI, Pfizer CentreOne, CordenPharma, Fujifilm Healthcare, Aumgene Biosciences, EKF Diagnostics, Biocon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Contract Pharmaceutical Fermentation Services Market Report Segments:
The global Contract Pharmaceutical Fermentation Services market is segmented on the basis of:
Types
Development Services, Commercial Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Biotechnology Companies, Animal Health Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Boehringer Ingelheim
- Lonza
- AMRI
- Pfizer CentreOne
- CordenPharma
- Fujifilm Healthcare
- Aumgene Biosciences
- EKF Diagnostics
- Biocon
Highlights of The Contract Pharmaceutical Fermentation Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Development Services
- Commercial Services
- By Application:
- Pharmaceutical Companies
- Biotechnology Companies
- Animal Health Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contract Pharmaceutical Fermentation Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Contract Pharmaceutical Fermentation Services is a service that helps pharmaceutical companies produce their products. This service involves the fermentation of drugs in large, industrial-scale tanks.
Some of the key players operating in the contract pharmaceutical fermentation services market are AbbVie, Boehringer Ingelheim, Lonza, AMRI, Pfizer CentreOne, CordenPharma, Fujifilm Healthcare, Aumgene Biosciences, EKF Diagnostics, Biocon.
The contract pharmaceutical fermentation services market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Pharmaceutical Fermentation Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Contract Pharmaceutical Fermentation Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Contract Pharmaceutical Fermentation Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Contract Pharmaceutical Fermentation Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Contract Pharmaceutical Fermentation Services Market Size & Forecast, 2018-2028
4.5.1 Contract Pharmaceutical Fermentation Services Market Size and Y-o-Y Growth
4.5.2 Contract Pharmaceutical Fermentation Services Market Absolute $ Opportunity
Chapter 5 Global Contract Pharmaceutical Fermentation Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
5.2.1 Development Services
5.2.2 Commercial Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contract Pharmaceutical Fermentation Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Biotechnology Companies
6.2.3 Animal Health Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contract Pharmaceutical Fermentation Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contract Pharmaceutical Fermentation Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Contract Pharmaceutical Fermentation Services Analysis and Forecast
9.1 Introduction
9.2 North America Contract Pharmaceutical Fermentation Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
9.6.1 Development Services
9.6.2 Commercial Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Biotechnology Companies
9.10.3 Animal Health Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Contract Pharmaceutical Fermentation Services Analysis and Forecast
10.1 Introduction
10.2 Europe Contract Pharmaceutical Fermentation Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
10.6.1 Development Services
10.6.2 Commercial Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Biotechnology Companies
10.10.3 Animal Health Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Contract Pharmaceutical Fermentation Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Contract Pharmaceutical Fermentation Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
11.6.1 Development Services
11.6.2 Commercial Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Biotechnology Companies
11.10.3 Animal Health Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Contract Pharmaceutical Fermentation Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Contract Pharmaceutical Fermentation Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
12.6.1 Development Services
12.6.2 Commercial Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Biotechnology Companies
12.10.3 Animal Health Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Contract Pharmaceutical Fermentation Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Contract Pharmaceutical Fermentation Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Contract Pharmaceutical Fermentation Services Market Size Forecast by Type
13.6.1 Development Services
13.6.2 Commercial Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Contract Pharmaceutical Fermentation Services Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Biotechnology Companies
13.10.3 Animal Health Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contract Pharmaceutical Fermentation Services Market: Competitive Dashboard
14.2 Global Contract Pharmaceutical Fermentation Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Boehringer Ingelheim
14.3.3 Lonza
14.3.4 AMRI
14.3.5 Pfizer CentreOne
14.3.6 CordenPharma
14.3.7 Fujifilm Healthcare
14.3.8 Aumgene Biosciences
14.3.9 EKF Diagnostics
14.3.10 Biocon
